CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study
Matthew J. Frank
, John H. Baird
, Anne Marijn Kramer
, Hrishikesh K. Srinagesh
, Shabnum Patel
, Annie Kathleen Brown
, Jean S. Oak
, Sheren F. Younes
, Yasodha Natkunam
, Mark P. Hamilton
, Yi Jiun Su
, Neha Agarwal
, Harshini Chinnasamy
, Emily Egeler
, Sharon Mavroukakis
, Steven A. Feldman
, Bita Sahaf
, Crystal L. Mackall
, Lori Muffly
, David B. Miklos
Research output: Contribution to journal › Article › peer-review
36Scopus
citations
Fingerprint
Dive into the research topics of 'CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study'. Together they form a unique fingerprint.